A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma

被引:125
|
作者
Hayashi, Akimasa [1 ,2 ]
Fan, Jun [1 ,2 ]
Chen, Ruoyao [3 ]
Ho, Yu-jui [4 ]
Makohon-Moore, Alvin P. [1 ,2 ]
Lecomte, Nicolas [1 ,2 ]
Zhong, Yi [1 ,2 ]
Hong, Jungeui [1 ,2 ]
Huang, Jinlong [1 ,2 ]
Sakamoto, Hitomi [1 ,2 ]
Attiyeh, Marc A. [1 ,2 ]
Kohutek, Zachary A. [1 ,2 ]
Zhang, Lance [1 ,2 ]
Boumiza, Aida [1 ,2 ]
Kappagantula, Rajya [1 ,2 ]
Baez, Priscilla [1 ,2 ]
Bai, Jessica [1 ,2 ]
Lisi, Marta [4 ]
Chadalavada, Kalyani [4 ]
Melchor, Jerry P. [1 ,2 ]
Wong, Winston [5 ]
Nanjangud, Gouri J. [4 ]
Basturk, Olca [6 ]
O'Reilly, Eileen M. [1 ,5 ]
Klimstra, David S. [1 ,6 ]
Hruban, Ralph H. [7 ]
Wood, Laura D. [7 ]
Overholtzer, Michael [3 ]
Iacobuzio-Donahue, Christine A. [1 ,2 ,6 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, David M Rubenstein Ctr Pancreat Canc Res, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Cell Biol Program, 1275 York Ave, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA
[5] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA
[6] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA
[7] Johns Hopkins Univ, Sch Med, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA
基金
美国国家卫生研究院;
关键词
SET ENRICHMENT ANALYSIS; ADENOSQUAMOUS CARCINOMA; MUTATIONAL LANDSCAPE; CANCER; GENE; MYC; SUBTYPES; COMPETITION; METABOLISM; EXPRESSION;
D O I
10.1038/s43018-019-0010-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Iacobuzio-Donahue and colleagues use integrated transcriptomic, histologic and mutational data to analyze squamous features of pancreatic ductal adenocarcinoma (PDAC), further refining the understanding of heterogeneity and evolution in PDAC. Pancreatic cancer expression profiles largely reflect a classical or basal-like phenotype. The extent to which these profiles vary within a patient is unknown. We integrated evolutionary analysis and expression profiling in multiregion-sampled metastatic pancreatic cancers, finding that squamous features are the histologic correlate of an RNA-seq-defined basal-like subtype. In patients with coexisting basal and squamous and classical and glandular morphology, phylogenetic studies revealed that squamous morphology represented a subclonal population in an otherwise classical and glandular tumor. Cancers with squamous features were significantly more likely to have clonal mutations in chromatin modifiers, intercellular heterogeneity for MYC amplification and entosis. These data provide a unifying paradigm for integrating basal-type expression profiles, squamous histology and somatic mutations in chromatin modifier genes in the context of clonal evolution of pancreatic cancer.
引用
收藏
页码:59 / +
页数:36
相关论文
共 50 条
  • [1] A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma
    Akimasa Hayashi
    Jun Fan
    Ruoyao Chen
    Yu-jui Ho
    Alvin P. Makohon-Moore
    Nicolas Lecomte
    Yi Zhong
    Jungeui Hong
    Jinlong Huang
    Hitomi Sakamoto
    Marc A. Attiyeh
    Zachary A. Kohutek
    Lance Zhang
    Aida Boumiza
    Rajya Kappagantula
    Priscilla Baez
    Jessica Bai
    Marta Lisi
    Kalyani Chadalavada
    Jerry P. Melchor
    Winston Wong
    Gouri J. Nanjangud
    Olca Basturk
    Eileen M. O’Reilly
    David S. Klimstra
    Ralph H. Hruban
    Laura D. Wood
    Michael Overholtzer
    Christine A. Iacobuzio-Donahue
    Nature Cancer, 2020, 1 : 59 - 74
  • [2] Heterogeneity of pancreatic ductal adenocarcinoma visualized
    Veenstra, Veronique
    Damhofer, Helene
    van Leusden, Tom
    Kessler, Jan
    Medema, Jan Paul
    van Laarhoven, Hanneke
    Vermeulen, Louis
    Bijlsma, Maarten
    CANCER RESEARCH, 2015, 75
  • [3] Features of immunophenotype of pancreatic ductal adenocarcinoma
    Evseyev, A. V.
    ZAPOROZHYE MEDICAL JOURNAL, 2014, (06) : 87 - 89
  • [4] Heterogeneity of KRAS Mutations in Pancreatic Ductal Adenocarcinoma
    Hashimoto, Daisuke
    Arima, Kota
    Yokoyama, Naomi
    Chikamoto, Akira
    Taki, Katsunobu
    Inoue, Risa
    Kaida, Takayoshi
    Higashi, Takaaki
    Nitta, Hidetoshi
    Ohmuraya, Masaki
    Hirota, Masahiko
    Beppu, Toru
    Baba, Hideo
    PANCREAS, 2016, 45 (08) : 1111 - 1114
  • [5] The molecular and cellular heterogeneity of pancreatic ductal adenocarcinoma
    Samuel, Nardin
    Hudson, Thomas J.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2012, 9 (02) : 77 - 87
  • [6] Targeting metabolic heterogeneity in pancreatic ductal adenocarcinoma
    Morningstar, Taryn
    Anaraki, Cecily
    Scipioni, Lorenzo
    Tedeschi, Giulia
    Digman, Michelle
    Edinger, Aimee
    Jorgensen, Claus
    Fishel, Melissa
    Halbrook, Christopher J.
    CANCER RESEARCH, 2024, 84 (17)
  • [7] The molecular and cellular heterogeneity of pancreatic ductal adenocarcinoma
    Nardin Samuel
    Thomas J. Hudson
    Nature Reviews Gastroenterology & Hepatology, 2012, 9 : 77 - 87
  • [8] Leukocyte Heterogeneity in Pancreatic Ductal Adenocarcinoma: Phenotypic and Spatial Features Associated with Clinical Outcome
    Liudahl, Shannon M.
    Betts, Courtney B.
    Sivagnanam, Shamilene
    Morales-Oyarvide, Vicente
    da Silva, Annacarolina
    Yuan, Chen
    Hwang, Samuel
    Grossblatt-Wait, Alison
    Leis, Kenna R.
    Larson, William
    Lavoie, Meghan B.
    Robinson, Padraic
    Costa, Andressa Dias
    Vayrynen, Sara A.
    Clancy, Thomas E.
    Rubinson, Douglas A.
    Link, Jason
    Keith, Dove
    Horton, Wesley
    Tempero, Margaret A.
    Vonderheide, Robert H.
    Jaffee, Elizabeth M.
    Sheppard, Brett
    Goecks, Jeremy
    Sears, Rosalie C.
    Park, Byung S.
    Mori, Motomi
    Nowak, Jonathan A.
    Wolpin, Brian M.
    Coussens, Lisa M.
    CANCER DISCOVERY, 2021, 11 (08) : 2014 - 2031
  • [9] The Countdown to a Paradigm Shift in Diagnosing Pancreatic Ductal Adenocarcinoma
    Cote, Gregory A.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (07) : 1000 - 1002
  • [10] Fibroblast heterogeneity in pancreatic ductal adenocarcinoma: Perspectives in immunotherapy
    Luong, Tha
    Golivi, Yuvasri
    Nagaraju, Ganji Purnachandra
    El-Rayes, Bassel F.
    CYTOKINE & GROWTH FACTOR REVIEWS, 2022, 68 : 107 - 115